Medtronic plc (MDT)
NYSE: MDT · Real-Time Price · USD
97.70
+2.22 (2.33%)
At close: Oct 3, 2025, 4:00 PM EDT
97.70
0.00 (0.00%)
After-hours: Oct 3, 2025, 4:15 PM EDT
Medtronic Revenue
Medtronic had revenue of $8.58B in the quarter ending July 25, 2025, with 8.38% growth. This brings the company's revenue in the last twelve months to $34.20B, up 4.98% year-over-year. In the fiscal year ending April 25, 2025, Medtronic had annual revenue of $33.54B with 3.62% growth.
Revenue (ttm)
$34.20B
Revenue Growth
+4.98%
P/S Ratio
3.58
Revenue / Employee
$360,000
Employees
95,000
Market Cap
125.32B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Apr 25, 2025 | 33.54B | 1.17B | 3.62% |
| Apr 26, 2024 | 32.36B | 1.14B | 3.64% |
| Apr 28, 2023 | 31.23B | -459.00M | -1.45% |
| Apr 29, 2022 | 31.69B | 1.57B | 5.21% |
| Apr 30, 2021 | 30.12B | 1.20B | 4.16% |
| Apr 24, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 26, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 27, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 28, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 29, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
MDT News
- 4 days ago - Medtronic Announces Closing of Public Offering of €1.5 Billion of Senior Notes - PRNewsWire
- 8 days ago - Medtronic: FY26 Outlook Strengthened By New Product Launches - Seeking Alpha
- 9 days ago - Medtronic plc (MDT) Presents at Bank of America Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 14 days ago - Medtronic secures FDA approval for the Altaviva™ device, a simple experience for treating urge urinary incontinence - PRNewsWire
- 16 days ago - Medtronic: Buy This Dividend Aristocrat While It's Good Value - Seeking Alpha
- 16 days ago - Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields - Benzinga
- 17 days ago - Medtronic Announces Pricing of €1.5 Billion of Senior Notes - PRNewsWire
- 18 days ago - Medtronic initiates global pivotal study of cardiac pacing in a new patient population - PRNewsWire